Genpact Limited
NYSEGenpact reported Q2 results on August 7 and the stock immediately punished the print, falling 5.2% on the day to $34.29 — reversing much of the month-long rally that had carried it up 15% into the release. The post-earnings reaction has reshuffled the analyst picture in real time. Seven firms moved their targets on results day, and the direction of travel was split. JP Morgan and TD…
G short interest surges 23.7% in one week to 7.4% of float, marking sharpest rally since April as short sellers build positions amid analyst downgrades and stock decline.
Snapshot as of 21 Sept 2026
Genpact reported Q2 results on August 7 and the stock immediately punished the print, falling 5.2% on the day to $34.29 — reversing much of the month-long rally that had carried it up 15% into the release. The…
Genpact enters its August 7 Q2 earnings release having staged an unusual turnaround in the lending market: short sellers have cut their exposure by more than 15% over the past month, pulling short interest down to 8.8%…
Genpact heads into tonight's Q1 results with options traders the most defensively positioned they've been in months — even as shorts quietly pull back. The clearest pre-earnings signal is in the options market. The…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for G — free to start on ORTEX.
Sign up for free →Open G on ORTEX